226. 間質性膀胱炎（ハンナ型） Interstitial cystitis with Hunners ulcer Clinical trials / Disease details

臨床試験数 : 143 / 薬物数 : 171 - (DrugBank : 56) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 145

88 trials found

diseases per page:

Showing 1 to 10 of 88 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04734106 (ClinicalTrials.gov)	May 2022	27/1/2021	Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis	A Double-Blind, Placebo-Controlled Study to Establish the Safety and Efficacy of Super-Concentrated, ...	Interstitial Cystitis;Chronic Interstitial Cystitis;Bladder Pain Syndrome	Drug: Desert Harvest Aloe Vera Capsules;Other: Placebo Capsules	Wake Forest University Health Sciences	Desert Harvest	Not yet recruiting	18 Years	N/A	All	100	Early Phase 1	United States
2	NCT04845217 (ClinicalTrials.gov)	September 15, 2021	29/3/2021	Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome	Efficacy of Peppermint Oil in a Randomized, Single-Blind, PlaceboControlled Trial in Women With Inte ...	Interstitial Cystitis	Drug: Peppermint oil;Drug: Coconut Oil	University of Louisville	Integrative Therapeutics, Inc.	Recruiting	18 Years	65 Years	Female	100	Phase 1/Phase 2	United States
3	NCT04313972 (ClinicalTrials.gov)	September 7, 2021	16/3/2020	IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone	IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone, the Effect of Low Dose Naltre ...	Interstitial Cystitis;Painful Bladder Syndrome;Bladder Pain Syndrome;Low Dose Naltrexone;Low-dose Na ...	Drug: low-dose naltrexone;Drug: Placebo oral tablet	NorthShore University HealthSystem	NULL	Recruiting	18 Years	110 Years	Female	44	Phase 4	United States
4	NCT04349930 (ClinicalTrials.gov)	January 2021	13/4/2020	The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Ur ...	The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Ur ...	Interstitial Cystitis;Bladder Pain Syndrome	Drug: Cannabidiol vaginal suppository;Drug: Placebo vaginal suppository	University of New Mexico	NULL	Withdrawn	18 Years	N/A	Female	0	Phase 1	United States
5	NCT04450316 (ClinicalTrials.gov)	October 8, 2020	24/6/2020	Low-dose Naltrexone for Bladder Pain Syndrome	Low-dose Naltrexone for Bladder Pain Syndrome: A Randomized Placebo-controlled Prospective Pilot Tri ...	Bladder Pain Syndrome;Interstitial Cystitis	Drug: Naltrexone;Drug: Placebo	Stanford University	NULL	Recruiting	18 Years	N/A	All	40	Phase 2	United States
6	NCT04208087 (ClinicalTrials.gov)	March 30, 2020	25/11/2019	PK and Safety of SI-722 in IC/BPS	A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmaco ...	Interstitial Cystitis;Bladder Pain Syndrome	Drug: SI-722;Drug: Placebo	Seikagaku Corporation	NULL	Completed	18 Years	80 Years	All	33	Phase 1/Phase 2	United States
7	NCT03844412 (ClinicalTrials.gov)	November 4, 2019	15/2/2019	Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments	Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments	Vestibulodynia;Temporomandibular Disorder;Fibromyalgia Syndrome;Irritable Bowel Syndrome;Migraines;T ...	Drug: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream;Drug: Nortriptyline;Drug: Placebocream;Dru ...	Duke University	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Recruiting	18 Years	50 Years	Female	400	Phase 2	United States
8	EUCTR2016-004138-12-BE (EUCTR)	27/11/2017	19/07/2017	Study of the effect of ASP6294 for the treatment of Bladder Pain Syndrome/Interstitial Cystitis in f ...	A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof of Concept Study to ...	Bladder Pain Syndrome/Interstitial Cystitis (BPC/IC) MedDRA version: 20.0;Level: LLT;Classification ...	Product Name: ASP6294 INN or Proposed INN: Not applicable Other descriptive name: ASP6294	Astellas Pharma Europe B.V.	NULL	Not Recruiting			Female: yes Male: no	163	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Hungary;Czech Republic;Poland;Spain;Belgium;Russian Federation;Netherlands;Latvia;Germany;United Kin ...
9	EUCTR2016-004138-12-GB (EUCTR)	30/10/2017	17/07/2017	Study of the effect of ASP6294 for the treatment of Bladder Pain Syndrome/Interstitial Cystitis in f ...	A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof of Concept Study to ...	Bladder Pain Syndrome/Interstitial Cystitis (BPC/IC) MedDRA version: 20.0;Level: LLT;Classification ...	Product Name: ASP6294 INN or Proposed INN: Not applicable Other descriptive name: ASP6294	Astellas Pharma Europe B.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: no	163	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Hungary;Czech Republic;Poland;Belgium;Spain;Russian Federation;Netherlands;Latvia;Germany;United Kin ...
10	EUCTR2016-004138-12-NL (EUCTR)	23/10/2017	24/07/2017	Study of the effect of ASP6294 for the treatment of Bladder Pain Syndrome/Interstitial Cystitis in f ...	A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof of Concept Study to ...	Bladder Pain Syndrome/Interstitial Cystitis (BPC/IC) MedDRA version: 20.0;Level: LLT;Classification ...	Product Name: ASP6294 INN or Proposed INN: Not Applicable Other descriptive name: ASP6294	Astellas Pharma Europe B.V.	NULL	Not Recruiting			Female: yes Male: no	163	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Hungary;Czech Republic;Poland;Belgium;Spain;Russian Federation;Latvia;Germany;Netherlands;United Kin ...

First Previous1 2 3 4 5…9Next Last